Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn NIH grant/contract attribution for 2015 was added, and the page revision text was updated from v3.6.5 to v3.6.6, reflecting a minor version update in the page’s metadata.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's backend or UI. The study content appears unchanged.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a new build/version of the page.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows a new revision tag: from v3.6.0 to v3.6.2, signaling a newer version of the page software. This reflects maintenance or bug fixes rather than updates to the study content.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now shows the study is no longer recruiting participants, and new help sections have been added to guide users on reading the study record and joining a study. The Intervention/Treatment header formatting was adjusted and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.